Hartley-Sharpe C J, Booth H, Johns D P, Walters E H
Department of Respiratory Medicine, Alfred Hospital, Melbourne, Victoria.
Thorax. 1995 Jun;50(6):635-8. doi: 10.1136/thx.50.6.635.
The DeVilbiss 40 glass hand held nebulisers have been widely used for airways responsiveness testing in epidemiological surveys of asthma. These nebulisers have been superseded in some recent studies by the DeVilbiss 45 plastic hand held nebulisers with the assumption that they are interchangeable. This study compared the aerosol outputs of the DeVilbiss 40 and DeVilbiss 45 nebulisers and investigated whether there was any difference in the in vivo measurements of airways responsiveness when using the two nebuliser types.
The aerosol output of six DeVilbiss 40 and six DeVilbiss 45 nebulisers was calculated by weight loss per actuation, the usual method of calibrating nebuliser output, and compared with the true amount of aerosol obtained measured by a flouride tracer technique. Airways responsiveness was measured twice in 13 asthmatic patients under identical conditions by the Yan protocol using DeVilbiss 40 and 45 nebulisers in random order.
Weight loss overestimated the true aerosol output of both types of nebulisers. Weight loss was similar for the DeVilbiss 40 and 45 nebulisers but the true aerosol output of the DeVilbiss 45 was nearly twice that of the DeVilbiss 40 nebuliser. The geometric mean PD20 values with the DeVilbiss 40 nebuliser was a mean 1.7 doubling doses of histamine higher than that obtained with the DeVilbiss 45 nebuliser.
The DeVilbiss 40 and 45 nebulisers should not be used interchangeably for airways responsiveness testing merely because their outputs based on weight loss are similar. Artefactual differences in the prevalence rates of airways responsiveness could occur in longitudinal studies if a change was inadvertently made from using DeVilbiss 40 to DeVilbiss 45 nebulisers.
德维比斯40型玻璃手持式雾化器在哮喘流行病学调查中被广泛用于气道反应性测试。在一些近期研究中,这些雾化器已被德维比斯45型塑料手持式雾化器取代,人们认为它们是可互换的。本研究比较了德维比斯40型和45型雾化器的气溶胶输出量,并调查了使用这两种雾化器类型时气道反应性的体内测量是否存在差异。
通过每次启动时的重量损失(校准雾化器输出的常用方法)计算六个德维比斯40型和六个德维比斯45型雾化器的气溶胶输出量,并与通过氟化物示踪技术测量得到的实际气溶胶量进行比较。13名哮喘患者按照随机顺序,使用德维比斯40型和45型雾化器,通过扬氏方案在相同条件下测量两次气道反应性。
重量损失高估了两种类型雾化器的实际气溶胶输出量。德维比斯40型和45型雾化器的重量损失相似,但德维比斯45型的实际气溶胶输出量几乎是德维比斯40型雾化器的两倍。使用德维比斯40型雾化器时的几何平均PD20值比使用德维比斯45型雾化器时高出组胺平均1.7倍剂量。
德维比斯40型和45型雾化器不应仅仅因为基于重量损失的输出量相似就互换用于气道反应性测试。如果在纵向研究中无意中从使用德维比斯40型雾化器改为使用德维比斯45型雾化器,可能会出现气道反应性患病率的人为差异。